These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24304814)

  • 1. miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma.
    McGirt LY; Adams CM; Baerenwald DA; Zwerner JP; Zic JA; Eischen CM
    J Invest Dermatol; 2014 Apr; 134(4):1101-1107. PubMed ID: 24304814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
    Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
    Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
    Mehdi SJ; Moerman-Herzog A; Wong HK
    BMC Cancer; 2021 May; 21(1):492. PubMed ID: 33941102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.
    Sandoval J; Díaz-Lagares A; Salgado R; Servitje O; Climent F; Ortiz-Romero PL; Pérez-Ferriols A; Garcia-Muret MP; Estrach T; Garcia M; Nonell L; Esteller M; Pujol RM; Espinet B; Gallardo F
    J Invest Dermatol; 2015 Apr; 135(4):1128-1137. PubMed ID: 25405321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TOX expression and role in CTCL.
    McGirt LY; Degesys CA; Johnson VE; Zic JA; Zwerner JP; Eischen CM
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1497-502. PubMed ID: 27345620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines.
    Litvinov IV; Cordeiro B; Fredholm S; Ødum N; Zargham H; Huang Y; Zhou Y; Pehr K; Kupper TS; Woetmann A; Sasseville D
    Cell Cycle; 2014; 13(18):2975-82. PubMed ID: 25486484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway.
    Xia L; Wu L; Xia H; Bao J; Li Q; Chen X; Xia R
    Cell Cycle; 2019 Jul; 18(14):1635-1645. PubMed ID: 31213131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
    Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H
    Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas.
    Dusílková N; Bašová P; Polívka J; Kodet O; Kulvait V; Pešta M; Trněný M; Stopka T
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
    Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides.
    van Kester MS; Borg MK; Zoutman WH; Out-Luiting JJ; Jansen PM; Dreef EJ; Vermeer MH; van Doorn R; Willemze R; Tensen CP
    J Invest Dermatol; 2012 Aug; 132(8):2050-9. PubMed ID: 22513784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.
    Manfè V; Biskup E; Rosbjerg A; Kamstrup M; Skov AG; Lerche CM; Lauenborg BT; Odum N; Gniadecki R
    PLoS One; 2012; 7(1):e29541. PubMed ID: 22235305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma.
    Seto AG; Beatty X; Lynch JM; Hermreck M; Tetzlaff M; Duvic M; Jackson AL
    Br J Haematol; 2018 Nov; 183(3):428-444. PubMed ID: 30125933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma.
    Xu J; Huang H; Wang S; Chen Y; Yin X; Zhang X; Zhang Y
    Arch Dermatol Res; 2020 Sep; 312(7):513-525. PubMed ID: 31676945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides.
    Chong BF; Wilson AJ; Gibson HM; Hafner MS; Luo Y; Hedgcock CJ; Wong HK
    Clin Cancer Res; 2008 Feb; 14(3):646-53. PubMed ID: 18245523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-93 Targets p21 and Promotes Proliferation in Mycosis Fungoides T Cells.
    Gluud M; Fredholm S; Blümel E; Willerslev-Olsen A; Buus TB; Nastasi C; Krejsgaard T; Bonefeld CM; Woetmann A; Iversen L; Litman T; Geisler C; Ødum N; Lindahl LM
    Dermatology; 2021; 237(2):277-282. PubMed ID: 32335549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.
    García-Colmenero L; González J; Sandoval J; Guillén Y; Diaz-Lagares A; Andrades E; Iglesias A; Nonell L; Pujol RM; Bigas A; Espinosa L; Gallardo F
    Cells; 2020 Dec; 9(12):. PubMed ID: 33333886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
    Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
    Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma.
    Huang Y; Su MW; Jiang X; Zhou Y
    Blood; 2015 Feb; 125(9):1435-43. PubMed ID: 25548321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD31 in Mycosis Fungoides.
    Jankowska-Konsur A; Kobierzycki C; Grzegrzolka J; Piotrowska A; Gomulkiewicz A; Glatzel-Plucinska N; Olbromski M; Podhorska-Okolow M; Szepietowski JC; Dziegiel P
    Anticancer Res; 2016 Sep; 36(9):4575-82. PubMed ID: 27630298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.